These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 11572892)

  • 1. Elevated levels of plasma von Willebrand factor and the risk of macro- and microvascular disease in type 2 diabetic patients with microalbuminuria.
    Gaede P; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2001 Oct; 16(10):2028-33. PubMed ID: 11572892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria.
    Jager A; van Hinsbergh VW; Kostense PJ; Emeis JJ; Nijpels G; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
    Nephrol Dial Transplant; 2001 Mar; 16(3):529-36. PubMed ID: 11239027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy.
    Parving HH; Nielsen FS; Bang LE; Smidt UM; Svendsen TL; Chen JW; Gall MA; Rossing P
    Diabetologia; 1996 Dec; 39(12):1590-7. PubMed ID: 8960847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion.
    Stehouwer CD; Zellenrath P; Polak BC; Baarsma GS; Nauta JJ; Donker AJ; den Ottolander GJ
    Diabetologia; 1992 Jun; 35(6):555-9. PubMed ID: 1612229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial markers, von Willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: comparison of primary renal disease.
    Hirano T; Ookubo K; Kashiwazaki K; Tajima H; Yoshino G; Adachi M
    Clin Chim Acta; 2000 Sep; 299(1-2):65-75. PubMed ID: 10900293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure.
    Fioretto P; Stehouwer CD; Mauer M; Chiesura-Corona M; Brocco E; Carraro A; Bortoloso E; van Hinsbergh VW; Crepaldi G; Nosadini R
    Diabetologia; 1998 Feb; 41(2):233-6. PubMed ID: 9498659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
    Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
    Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group.
    Lacquemant C; Gaucher C; Delorme C; Chatellier G; Gallois Y; Rodier M; Passa P; Balkau B; Mazurier C; Marre M; Froguel P
    Kidney Int; 2000 Apr; 57(4):1437-43. PubMed ID: 10760079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K; Thompson C
    Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.
    Suguro T; Watanabe T; Kodate S; Xu G; Hirano T; Adachi M; Miyazaki A
    Clin Sci (Lond); 2008 Dec; 115(11):327-34. PubMed ID: 18338983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.
    Engelen L; Schalkwijk CG; Eussen SJ; Scheijen JL; Soedamah-Muthu SS; Chaturvedi N; Fuller JH; Stehouwer CD
    Cardiovasc Diabetol; 2015 May; 14():67. PubMed ID: 26025465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between serum uric acid level and microalbuminuria to chronic vascular complications in Thai patients with type 2 diabetes.
    Chuengsamarn S; Rattanamongkolgul S; Jirawatnotai S
    J Diabetes Complications; 2014; 28(2):124-9. PubMed ID: 24412514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease.
    Solerte SB; Piovella F; Viola C; Schianca GC; Gamba G; Fioravanti M; Ferrari E
    Acta Diabetol Lat; 1985; 22(3):239-46. PubMed ID: 3878055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno-2 study].
    Gaede PH; Jepsen PV; Parving HH; Pedersen OB
    Ugeskr Laeger; 1999 Jul; 161(30):4277-85. PubMed ID: 10439688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical trial of the month. The STENO-2 study: a plea for global and intensive management of the type 2 diabetic patient].
    Scheen AJ; Estrella F
    Rev Med Liege; 2003 Feb; 58(2):109-11. PubMed ID: 12693313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.